D2C-firstUS

cbdMD benchmarks

YCBD · United States

How cbdMD runs its business, at a glance: $19M in revenue in fiscal 2025 (-3.7%), compared with 30 other D2C-first brands on growth, margins and marketing. 10 fiscal years since 2016 and 30 quarters from SEC filings.

Compare your brandSee peersFull history

Revenue, FY 2025$19M-3.7% on the year before · #169 of 180 by revenue
Growth-3.7%Below the D2C-first median
Gross margin62.4%Above the D2C-first median
Marketing–Not reported
Operating margin-11.3%Below the D2C-first median

Operating scorecard

The numbers that show how cbdMD runs: what it keeps from each sale, what it spends to win customers, and what is left. Each card shows the trend and where cbdMD ranks.

Revenue, FY 2025

$19M-3.7% on a year earlier

In USD, as reported.

2016: $2M2017: $4.5M2018: $459K2019: $24M2020: $42M2021: $47M2022: $37M2023: $25M2024: $20M2025: $19M
20162025

#169 by revenue of 180 brands in the benchmark.

Revenue growth

-3.7%▲ 16.8 pts vs 2024

Revenue against the year before

2017: +120.3% (peer median +12.1%)2018: -89.7% (peer median +14%)2019: +5051.8% (peer median +16.7%)2020: +77.1% (peer median +37.4%)2021: +13% (peer median +25.7%)2022: -21.6% (peer median +4.3%)2023: -32.5% (peer median -0.7%)2024: -20.5% (peer median -0.9%)2025: -3.7% (peer median +3.6%)
2016peer median2025

Below the D2C-first median (+4.1%). Grows faster than 27% of all 174 brands.

Gross margin

62.4%▲ 2.2 pts vs 2024

Left of each sale after product and delivery costs

2016: 20.3% (peer median 46.8%)2017: 69.7% (peer median 43.2%)2018: 77.3% (peer median 43.9%)2019: 61.4% (peer median 47%)2020: 63% (peer median 46.5%)2021: 63.4% (peer median 49.2%)2022: 60.2% (peer median 47.1%)2023: 59.8% (peer median 49.7%)2024: 60.2% (peer median 50.4%)2025: 62.4% (peer median 54.3%)
2016peer median2025

Above the D2C-first median (54.6%). Higher margin than 76% of all 169 brands.

Marketing spend

–

Share of revenue spent on marketing and advertising

2016: 33% (peer median 10.8%)2017: 7.9% (peer median 13.3%)2018: 31.3% (peer median 16.8%)2019: 21.8% (peer median 19.6%)2020: 23.7% (peer median 21.4%)
2016peer median2025

Not reported.

Headroom

–

Gross margin minus marketing: what is left for the team, rent and profit

2016: -12.6% (peer median 34.9%)2017: 61.8% (peer median 28.5%)2018: 46% (peer median 23.7%)2019: 39.6% (peer median 29.1%)2020: 39.2% (peer median 28.4%)
2016peer median2025

Not reported.

Operating margin

-11.3%▲ 5.4 pts vs 2024

Profit from operations, before interest and tax

2016: -191.4% (peer median +0.9%)2017: -30.4% (peer median -4.4%)2018: -391.4% (peer median -4.7%)2019: -62.6% (peer median -4.2%)2020: -42% (peer median +4.2%)2021: -41.4% (peer median +4.5%)2022: -210.8% (peer median -0.1%)2023: -89.8% (peer median -4.2%)2024: -16.6% (peer median +1.4%)2025: -11.3% (peer median +1.7%)
2016peer median2025

Below the D2C-first median (+2.1%). More profitable than 19% of all 178 brands.

cbdMD: FY 2025. Trend lines: the last 10 fiscal years, dashed line the median D2C-first brand in the same year. Bars: where cbdMD sits among all 180 brands, from lowest to highest.

Where every 100 of revenue goes

For every 100 cbdMD takes in: what the products cost to make and deliver, what goes to marketing, what runs the company, and what is left as profit.

Product and deliveryMarketingTeam, rent and other costsOperating profitLoss (costs above revenue)

cbdMDFY 2025
cbdMDFY 2016
D2C-first median30 brands
All brands median180 brands

Medians are worked out line by line, so their parts can add up to slightly more or less than 100. Product and delivery is revenue minus gross profit; how much shipping sits there differs by company.

Compare your brand

Type in your own numbers to see where you stand against cbdMD, the median D2C-first brand, and all 180 brands.

Your last 12 months, as % of revenue. Nothing you type leaves this page.

Your numbers against cbdMD and the D2C-first median
MetricYoucbdMDGapD2C-firstmedianAmong all brands
Revenue growth–-3.7%–+4.1%–
Gross margin–62.4%–54.6%–
Marketing spend–––16.4%–
Headroom–––32%–
Operating margin–-11.3%–+2.1%–

cbdMD and its peers

D2C-first brands of a similar size, side by side.

All D2C-first brands
cbdMD and the closest D2C-first brands by revenue
BrandRevenueGrowthGross marginMarketingHeadroomOp. margin
elumeoELB · Europe €39M-9.9%47.8%6.7%41.1%-6.4%
Willamette Valley VineyardsWVVI · US $38M+2.5%59.1%46.9%12.2%-7.6%
Axil BrandsAXIL · US $31M+17.5%69.3%39.4%29.9%+9.7%
Luvu BrandsLUVU · US $27M+5.8%31.5%3.5%28%+3.2%
Perfect MomentPMNT · US $24M+9.8%67.6%13.7%53.9%-22.2%
cbdMDYCBD · US $19M-3.7%62.4%––-11.3%
FitLife BrandsFTLF · US $16M-75.3%43.1%––+18.6%
GMEX RoboticsGMEX · US $5.6M+7.9%8.6%9.7%-1.2%-127.1%
D2C-first median30 brands+4.1%54.6%16.4%32%+2.1%

The 7 D2C-first brands closest to cbdMD in revenue. Green: above the median, grey: below. Revenue in each company's own currency.

Revenue by year

Every fiscal year on record, in USD. Point at a bar for growth and margins.

FY 2016: revenue $2M, gross margin 20.3%, marketing 33%, operating margin -191.4% $2M 2016FY 2017: revenue $4.5M, +120.3% on a year earlier, gross margin 69.7%, marketing 7.9%, operating margin -30.4% $4.5M 2017FY 2018: revenue $459K, -89.7% on a year earlier, gross margin 77.3%, marketing 31.3%, operating margin -391.4% $459K 2018FY 2019: revenue $24M, +5051.8% on a year earlier, gross margin 61.4%, marketing 21.8%, operating margin -62.6% $24M 2019FY 2020: revenue $42M, +77.1% on a year earlier, gross margin 63%, marketing 23.7%, operating margin -42% $42M 2020FY 2021: revenue $47M, +13% on a year earlier, gross margin 63.4%, operating margin -41.4% $47M 2021FY 2022: revenue $37M, -21.6% on a year earlier, gross margin 60.2%, operating margin -210.8% $37M 2022FY 2023: revenue $25M, -32.5% on a year earlier, gross margin 59.8%, operating margin -89.8% $25M 2023FY 2024: revenue $20M, -20.5% on a year earlier, gross margin 60.2%, operating margin -16.6% $20M 2024FY 2025: revenue $19M, -3.7% on a year earlier, gross margin 62.4%, operating margin -11.3% $19M 2025
RevenueGross margin (0–100% scale)Marketing (0–100% scale)
cbdMD by fiscal year
Fiscal yearRevenueGrowthGross marginMarketingOp. marginNet marginSource
2025ends 2025-09-30 $19M-3.7%62.4% –-11.3%-10.6% 10-K filed 2025-12-19
2024ends 2024-09-30 $20M-20.5%60.2% –-16.6%-18.6% 10-K filed 2025-12-19
2023ends 2023-09-30 $25M-32.5%59.8% –-89.8%-91.6% 10-K filed 2024-12-18
2022ends 2022-09-30 $37M-21.6%60.2% –-210.8%-188.8% 10-K filed 2023-12-22
2021ends 2021-09-30 $47M+13%63.4% –-41.4%-49.4% 10-K filed 2022-12-15
2020ends 2020-09-30 $42M+77.1%63% 23.7%-42%+30.1% 10-K filed 2021-12-17
2019ends 2019-09-30 $24M+5051.8%61.4% 21.8%-62.6%-217.1% 10-K filed 2020-12-22
2018ends 2018-09-30 $459K-89.7%77.3% 31.3%-391.4%+13.7% 10-K filed 2019-12-18
2017ends 2017-09-30 $4.5M+120.3%69.7% 7.9%-30.4%-31% 10-K filed 2018-12-12
2016ends 2016-09-30 $2M–20.3% 33%-191.4%-191.8% 10-K filed 2017-12-26

Revenue and margins by quarter

The last 16 calendar quarters. Most companies only report Q4 inside their annual report, so Q4 is the full year minus the first three quarters.

Q2 2021: revenue $11M, +6.7% on a year earlier, gross margin 63.3%, operating margin -58.8% Q4 2021: revenue $9.9M, -20% on a year earlier, gross margin 50.7%, operating margin -255.1% Q4 2021Q1 2022: revenue $9.9M, -15.7% on a year earlier, gross margin 64.8%, operating margin -50.4% Q2 2022: revenue $8.9M, -21.9% on a year earlier, gross margin 66.9%, operating margin -373.5% Q2 2022Q4 2022: revenue $6.2M, -36.7% on a year earlier, gross margin 57.2%, operating margin -64.8% Q1 2023: revenue $6.6M, -33.8% on a year earlier, gross margin 61%, operating margin -21.3% Q1 2023Q2 2023: revenue $6.5M, -27.1% on a year earlier, gross margin 59.5%, operating margin -28.2% Q4 2023: revenue $5.4M, -13.9% on a year earlier, gross margin 66.2%, operating margin -19.8% Q4 2023Q1 2024: revenue $4.8M, -26.9% on a year earlier, gross margin 53.6%, operating margin -32.2% Q2 2024: revenue $5.2M, -19.9% on a year earlier, gross margin 65.8%, operating margin -7.4% Q2 2024Q4 2024: revenue $5.1M, -4.9% on a year earlier, gross margin 66.5%, operating margin -1.7% Q1 2025: revenue $4.7M, -1.4% on a year earlier, gross margin 62.3%, operating margin -10.2% Q1 2025Q2 2025: revenue $4.6M, -11% on a year earlier, gross margin 61.5%, operating margin -19.6% Q4 2025: revenue $5M, -1.9% on a year earlier, gross margin 59.8%, operating margin -5.7% Q4 2025Q1 2026: revenue $5.6M, +18.8% on a year earlier, gross margin 57.7%, operating margin -14.2% Q2 2026: revenue $5.6M, +20.6% on a year earlier, gross margin 54.7%, operating margin -20.4% Q2 2026
RevenueGross margin (0–100% scale)
All 30 quarters
cbdMD by quarter
QuarterRevenuevs year earlierGross marginMarketingOp. marginSource
Q2 2026 $5.6M+20.6%54.7% –-20.4% 10-Q filed 2026-08-13
Q1 2026 $5.6M+18.8%57.7% –-14.2% 10-Q filed 2026-05-14
Q4 2025 $5M-1.9%59.8% –-5.7% 10-Q filed 2026-02-17
Q2 2025 $4.6M-11%61.5% –-19.6% 10-Q filed 2026-08-13
Q1 2025 $4.7M-1.4%62.3% –-10.2% 10-Q filed 2026-05-14
Q4 2024 $5.1M-4.9%66.5% –-1.7% 10-Q filed 2026-02-17
Q2 2024 $5.2M-19.9%65.8% –-7.4% 10-Q filed 2025-08-14
Q1 2024 $4.8M-26.9%53.6% –-32.2% 10-Q filed 2025-05-15
Q4 2023 $5.4M-13.9%66.2% –-19.8% 10-Q filed 2025-02-13
Q2 2023 $6.5M-27.1%59.5% –-28.2% 10-Q filed 2024-08-14
Q1 2023 $6.6M-33.8%61% –-21.3% 10-Q filed 2024-05-15
Q4 2022 $6.2M-36.7%57.2% –-64.8% 10-Q filed 2024-02-13
Q2 2022 $8.9M-21.9%66.9% –-373.5% 10-Q filed 2023-08-10
Q1 2022 $9.9M-15.7%64.8% –-50.4% 10-Q filed 2023-05-15
Q4 2021 $9.9M-20%50.7% –-255.1% 10-Q filed 2023-02-13
Q2 2021 $11M+6.7%63.3% –-58.8% 10-Q filed 2022-08-11
Q1 2021 $12M+25.5%69.1% –-35.3% 10-Q filed 2022-05-13
Q4 2020 $12M+21.5%72.2% –-14.3% 10-Q filed 2022-02-10
Q2 2020 $11M+32.9%64.8% 16%-12.6% 10-Q filed 2021-08-12
Q1 2020 $9.4M+66.8%70.9% 36.2%-59.6% 10-Q filed 2021-05-12
Q4 2019 $10M+2079.2%63.5% 23.8%-60.2% 10-Q filed 2021-02-09
Q2 2019 $8M+150.3%63.4% 32.3%-80.8% 10-Q filed 2020-08-12
Q1 2019 $5.6M+83%66% 26.2%-36% 10-Q filed 2020-05-15
Q4 2018 $466K-32.3%64.5% 1.7%-234.4% 10-Q filed 2020-02-13
Q2 2018 $3.2M+79%65.4% 13.9%+19.6% 10-Q filed 2019-08-14
Q1 2018 $3.1M+118.7%83% 8%+52.6% 10-Q filed 2019-05-15
Q4 2017 $688K+244.2%66.8% 49.7%-188.7% 10-Q/A filed 2019-04-26
Q2 2017 $1.8M–85.4% 8.7%-10% 10-Q filed 2018-08-14
Q1 2017 $1.4M–71.7% 7.4%-15% 10-Q filed 2018-05-15
Q4 2016 $200K–18.6% 15%-348% 10-Q filed 2018-02-14

Sources

Every figure is from cbdMD's SEC filings (XBRL data in its 10-K and 10-Q reports): all filings on SEC EDGAR. Each row above links to the filing it came from.

Marketing is whatever the company reports as marketing, advertising or selling and marketing, so definitions differ between companies. Rankings compare each brand's latest 12 months (US) or latest fiscal year (Europe).

All D2C benchmarks

From the team behind this directory

You've seen how cbdMD does it. Now see how yours compares.

Bratrax connects to your Shopify store and ad accounts and shows you the numbers that decide whether you're making money: profit after ad spend and product costs, which channels bring customers who come back, and where your next dollar should go.

$1 first month · then $99/month flat · no contract

  • Revenue, ad spend, MER and profit for the whole store on one screen
  • Every order traced back to the campaign that brought it
  • New vs. returning customers, cohorts and lifetime value
  • Email campaigns and flows, with the revenue they drove
  • Ask questions in plain English with your own Claude